Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients

References

• Zhuang Y, Wei X, Yu Y, Wang D. Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy. J Clin Apher. 2021;36(4):664–667. doi:10.1002/jca.21905
   Web of Science ®Google Scholar
• Zhu J, Yuan L, Ni WJ, Luo Y, Ma JH. Association of higher circulating insulin antibody with increased mean amplitude glycemic excursion in patients with type 2 diabetes mellitus: a cross-sectional, retrospective case-control study. J Diabetes Res. 2019;2019:7304140. doi:10.1155/2019/7304140
   PubMed Web of Science ®Google Scholar
• Masuda A, Tsushima T, Shizume K, et al. Insulin autoimmune syndrome with insulin-resistant diabetes at the incipient stage prior to hypoglycemic attacks. J Endocrinol Invest. 1986;9(6):507–512. doi:10.1007/bf03346977
   Web of Science ®Google Scholar
• Itoh A, Saisho Y, Mitsuishi M, et al. Insulin glulisine may ameliorate nocturnal hypoglycemia related to insulin antibody–a case report. Diabetes Res Clin Pract. 2011;94(2):e53–e54. doi:10.1016/j.diabres.2011.04.001
   Web of Science ®Google Scholar
• Ishizuka T, Ogawa S, Mori T, et al. Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. Diabetes Res Clin Pract. 2009;84(2):e21–e23. doi:10.1016/j.diabres.2009.02.007
   PubMedGoogle Scholar
• Hu X, Ma X, Wang X, et al. Insulin antibodies in patients with type 2 diabetic receiving recombinant human insulin injection: a report of 12 cases. Ann Endocrinol. 2015;76(6):694–697. doi:10.1016/j.ando.2015.10.004
   Web of Science ®Google Scholar
• Fineberg SE, Kawabata TT, Finco-Kent D, Fountaine RJ, Finch GL, Krasner AS. Immunological responses to exogenous insulin. Endocr Rev. 2007;28(6):625–652. doi:10.1210/er.2007-0002
   PubMed Web of Science ®Google Scholar
• Jagannathan R, Neves JS, Dorcely B, et al. The oral glucose tolerance test: 100 years later. Diabetes Metab Syndr Obes. 2020;13:3787–3805. doi:10.2147/DMSO.S246062
   PubMed Web of Science ®Google Scholar
• Kuo FY, Cheng KC, Li Y, Cheng JT. Oral glucose tolerance test in diabetes, the old method revisited. World J Diabetes. 2021;12(6):786–793. doi:10.4239/wjd.v12.i6.786
   Web of Science ®Google Scholar
• Censi S, Mian C, Betterle C. Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med. 2018;6(17):335. doi:10.21037/atm.2018.07.32
   PubMed Web of Science ®Google Scholar
• Lebowitz MR, Blumenthal SA. The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med. 1993;153(5):650–655. doi:10.1001/archinte.1993.00410050082011
   PubMedGoogle Scholar
• Kasayama S, Otsuki M, Takagi M, et al. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol (Oxf). 2000;52(5):549–555. doi:10.1046/j.1365-2265.2000.00986.x
   PubMed Web of Science ®Google Scholar
• Colagiuri S, Falavigna M, Agarwal MM, et al. Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Diabetes Res Clin Pract. 2014;103(3):364–372. doi:10.1016/j.diabres.2014.02.012
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295–301. doi:10.2337/diacare.23.3.295
   PubMed Web of Science ®Google Scholar
• Quan H, Tan H, Li Q, Li J, Li S. Immunological hypoglycemia associated with insulin antibodies induced by exogenous insulin in 11 Chinese patients with diabetes. J Diabetes Res. 2015;2015:746271. doi:10.1155/2015/746271
   PubMed Web of Science ®Google Scholar
• Zhao TY, Li F, Xiong ZY. Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies. Mol Diagn Ther. 2010;14(4):237–241. doi:10.1007/bf03256379
   PubMed Web of Science ®Google Scholar
• Hu X, Chen F. Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients. Endocr Connect. 2018;7(1):R47–R55. doi:10.1530/EC-17-0309
   PubMed Web of Science ®Google Scholar
• Shen Y, Song X, Ren Y. Insulin autoimmune syndrome induced by exogenous insulin injection: a four-case series. BMC Endocr Disord. 2019;19(1):148. doi:10.1186/s12902-019-0482-0
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Hirata Y, Omori Y. A novel concept of type VII hypersensitivity introduced by insulin autoimmune syndrome (Hirata’s disease). Autoimmunity. 1995;20(3):207–208. doi:10.3109/08916939508993352
   PubMed Web of Science ®Google Scholar
• Li Z, Yi D, Zheng L, Li S, Fang W, Wang C. Analysis of the clinical characteristics of insulin autoimmune syndrome induced by exogenous insulin in diabetic patients. Diabetol Metab Syndr. 2021;13(1). doi:10.1186/s13098-021-00658-z
   Web of Science ®Google Scholar
• Hattori N, Duhita MR, Mukai A, Matsueda M, Shimatsu A. Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes. Clin Chim Acta. 2014;433:135–138. doi:10.1016/j.cca.2014.03.008
   PubMed Web of Science ®Google Scholar
• Goldman J, Baldwin D, Rubenstein AH, et al. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest. 1979;63(5):1050–1059. doi:10.1172/JCI109374
   PubMed Web of Science ®Google Scholar
• Lv X, Fang K, Hao W, Han Y, Yang N, Yu Q. Identification of reactive hypoglycemia with different basic BMI and its causes by prolonged oral glucose tolerance test. Diabetes Metab Syndr Obes. 2020;13:4717–4726. doi:10.2147/DMSO.S280084
   PubMed Web of Science ®Google Scholar
• Sun Y, Han J, Lin Z, Song L, Wang C, Jia W. Delayed insulin secretion response during an OGTT is associated with an increased risk for incidence of diabetes in NGT subjects. J Diabetes Complications. 2016;30(8):1537–1543. doi:10.1016/j.jdiacomp.2016.07.029
   Web of Science ®Google Scholar
• Ismail AAA. The double whammy of endogenous insulin antibodies in non-diabetic subjects. Clin Chem Lab Med. 2008;46(2):153–156. doi:10.1515/CCLM.2008.031
   PubMed Web of Science ®Google Scholar
• Egawa T, Tsuneshige A, Suematsu M, Yonetani T. Method for determination of association and dissociation rate constants of reversible bimolecular reactions by isothermal titration calorimeters. Anal Chem. 2007;79(7):2972–2978. doi:10.1021/ac062183z
   Web of Science ®Google Scholar
• Huynh T. Clinical and laboratory aspects of insulin autoantibody-mediated glycaemic dysregulation and hyperinsulinaemic hypoglycaemia: insulin autoimmune syndrome and exogenous insulin antibody syndrome. Clin Biochem Rev. 2020;41(3):93–102. doi:10.33176/AACB-20-00008
   Google Scholar
• Wong SL, Priestman A, Holmes DT. Recurrent hypoglycemia from insulin autoimmune syndrome. J Gen Intern Med. 2014;29(1):250–254. doi:10.1007/s11606-013-2588-9
   PubMed Web of Science ®Google Scholar
• Yuan T, Li J, Li M, et al. Insulin autoimmune syndrome diagnosis and therapy in a single Chinese center. Clin Ther. 2019;41(5):920–928. doi:10.1016/j.clinthera.2019.03.009
   PubMed Web of Science ®Google Scholar